IMHA in Dogs: Immune-Mediated Hemolytic Anemia

Vet Teletriage

Worried this is an emergency? Talk to a vet now.

Sidekick.Vet connects you with licensed veterinary professionals for urgent teletriage — get fast guidance on whether your pet needs emergency care. Just $35, no subscription.

Get Help at Sidekick.Vet →
Quick Answer
  • See your vet immediately if your dog has pale or yellow gums, weakness, fast breathing, collapse, or dark orange-brown urine. IMHA can become life-threatening within hours to days.
  • IMHA happens when the immune system destroys red blood cells faster than the body can replace them, causing severe anemia and often jaundice.
  • Diagnosis usually includes a CBC, blood smear, saline agglutination testing, chemistry panel, urinalysis, and testing for triggers such as tick-borne disease, cancer, drugs, or zinc exposure.
  • Treatment often combines hospitalization, blood transfusion support when needed, corticosteroids, anti-clotting medication, and sometimes a second immunosuppressive drug.
  • Blood clots are one of the most dangerous complications. Dogs that make it through the first 1 to 2 weeks often have a better outlook, but relapses can happen during medication tapering.
Estimated cost: $1,500–$12,000

What Is IMHA?

Immune-mediated hemolytic anemia, or IMHA, is a disease where a dog’s immune system mistakenly attacks its own red blood cells. Those cells carry oxygen through the body, so when they are destroyed too quickly, the result is anemia, weakness, poor oxygen delivery, and sometimes shock. IMHA is considered a true veterinary emergency.

In many dogs, antibodies attach to red blood cells and mark them for destruction in the spleen and liver. Some dogs also have red blood cells destroyed directly within the bloodstream. As those cells break apart, bilirubin levels can rise, which is why some dogs develop yellow gums, yellow eyes, or orange to brown urine.

Vets usually divide IMHA into primary IMHA, where no clear trigger is found, and secondary IMHA, where another problem appears to have set off the immune attack. Secondary triggers can include infectious disease, inflammation, cancer, certain drugs, or zinc toxicity. Even when a trigger is found, treatment still focuses on stabilizing the dog and slowing immune destruction.

IMHA is one of the more serious immune-mediated diseases seen in dogs. It can respond well to treatment in some patients, but it often requires close monitoring, repeated bloodwork, and weeks to months of follow-up with your vet.

Signs of IMHA

  • Pale, white, or light pink gums — often an early sign of significant anemia
  • Yellow gums, skin, or whites of the eyes — suggests jaundice from red blood cell breakdown
  • Sudden weakness, exercise intolerance, or sleeping much more than usual
  • Rapid breathing or panting at rest — can happen when oxygen delivery is poor
  • Fast heart rate or strong pounding heartbeat
  • Dark orange, tea-colored, red, or brown urine
  • Poor appetite or refusing food
  • Vomiting or nausea
  • Fever
  • Mental dullness, wobbliness, or collapse
  • Cold limbs or signs of poor circulation in severe cases
  • Enlarged spleen or enlarged liver found during your vet’s exam

Some dogs look mildly tired at first, while others become critically ill very quickly. Pale gums, yellow discoloration, dark urine, fast breathing, or collapse are high-concern signs and should be treated as an emergency. See your vet immediately if your dog seems weak and anemic, especially if the signs appeared over a day or two rather than gradually.

What Causes IMHA?

In primary IMHA, no single trigger is identified. This is common in dogs, and many specialists believe genetics, immune dysregulation, and environmental factors all play a role. Certain breeds appear overrepresented, which supports a hereditary component in at least some cases.

In secondary IMHA, your vet looks for something that may have triggered the immune system to target red blood cells. Reported triggers include tick-borne or other infectious diseases, cancer, inflammatory disease, drug reactions, and zinc toxicity. Zinc exposure is especially important because swallowed pennies, hardware, ointment tubes, or supplements can cause hemolysis in some dogs.

A recent vaccine is sometimes mentioned in a dog’s history, but that does not automatically mean the vaccine caused the IMHA. In practice, your vet will look at timing, the dog’s full medical picture, and whether another trigger is more likely. The goal is not to blame one event too quickly, but to identify anything treatable that could change the care plan.

Breeds commonly reported at higher risk include Cocker Spaniels, Springer Spaniels, Poodles, Old English Sheepdogs, Irish Setters, and Collies. Middle-aged dogs are diagnosed often, and females may be affected somewhat more often than males.

How Is IMHA Diagnosed?

IMHA is not diagnosed from one test alone. Your vet usually combines the history, physical exam, and lab findings to confirm that red blood cells are being destroyed and that immune-mediated disease is likely. A complete blood count (CBC) shows how severe the anemia is and whether the bone marrow is trying to respond by releasing immature red blood cells.

A blood smear is very important. It can show spherocytes, which are small red blood cells commonly seen with immune destruction, and it can help identify autoagglutination, where red blood cells clump together. A saline agglutination test may be done in the clinic, and a direct antiglobulin (Coombs) test can support the diagnosis in some cases, although a negative result does not rule IMHA out.

Most dogs also need a chemistry panel and urinalysis. These tests help look for bilirubin elevation, organ stress, pigment in the urine, dehydration, and complications that may affect treatment choices. Because IMHA can be secondary to another disease, your vet may also recommend tick-borne disease testing, chest X-rays, abdominal ultrasound, or other screening based on your dog’s age and exam findings.

Clotting risk matters too. Dogs with IMHA are prone to thromboembolism, including life-threatening clots in the lungs. That is one reason many dogs are hospitalized early, even if they are still standing and alert when they first arrive.

Treatment Options for IMHA

Spectrum of Care means you have options. Here are treatment tiers at different price points.

Stabilization With Essential Inpatient Care

$1,500–$3,500
Best for: Dogs that are stable enough to start treatment without ICU-level care, or pet parents who need a practical first step while still addressing the emergency
  • Exam, CBC/PCV checks, blood smear review, chemistry panel, and urinalysis
  • Short hospitalization for oxygen support, careful IV fluids if needed, and serial monitoring
  • Corticosteroid treatment such as prednisone or dexamethasone, based on your vet’s plan
  • Anti-clotting medication such as clopidogrel or another thromboprophylaxis plan chosen by your vet
  • GI support medications when steroid side effects are a concern
  • Focused screening for obvious triggers, such as zinc exposure or common infectious disease risks
Expected outcome: Variable. Some dogs respond to first-line care over several days, while others worsen quickly and need transfusion or referral. Close rechecks are essential.
Consider: Lower upfront cost range, but less intensive monitoring than specialty hospitalization. If anemia drops further or clotting complications develop, the plan may need to escalate quickly.

Specialty and Critical Care Management

$8,000–$12,000
Best for: Dogs with severe anemia, collapse, clotting complications, poor response to first-line treatment, or complex secondary disease
  • Internal medicine or critical care oversight
  • ICU hospitalization with continuous nursing care
  • Multiple transfusions, advanced crossmatching, and rapid response to transfusion needs
  • Management of thromboembolism, severe jaundice, organ complications, or disseminated intravascular coagulation
  • Advanced coagulation assessment where available
  • Use of less common rescue strategies for refractory cases, such as human IV immunoglobulin or splenectomy discussion in carefully selected patients
Expected outcome: Guarded. Some critically ill dogs recover with intensive care, but clotting complications and refractory hemolysis remain major causes of death.
Consider: Highest cost range and the most intensive care commitment. Not every dog needs this level of treatment, and not every region has specialty access, but it can be appropriate for unstable or nonresponsive cases.

Cost estimates as of 2026-03. Actual costs vary by location, clinic, and individual case.

Questions to Ask Your Vet About IMHA

Bring these questions to your vet appointment to get the most out of your visit.

  1. How severe is my dog’s anemia right now, and what numbers are you following each day?
  2. Does my dog need a blood transfusion now, or are we monitoring to see if the red blood cell count stabilizes?
  3. What findings make you confident this is IMHA rather than blood loss, toxin exposure, or another cause of anemia?
  4. What secondary causes have we checked for, such as tick-borne disease, cancer, inflammation, or zinc ingestion?
  5. What anti-clotting plan are you recommending, and what signs of a blood clot should I watch for at home?
  6. Are you recommending steroids alone or a second immunosuppressive medication too, and why?
  7. What side effects should I expect from these medications, and which ones mean I should call right away?
  8. How often will my dog need CBC rechecks, and how long does treatment usually continue before tapering?

Can IMHA Be Prevented?

Primary IMHA usually cannot be prevented because there is no single known cause. What you can do is lower the risk of some secondary triggers and catch problems early. Year-round parasite prevention, especially tick prevention in endemic areas, is one practical step. Keeping coins, zinc-containing creams, hardware, and supplements out of reach matters too.

If your dog starts a new medication and then develops pale gums, weakness, jaundice, or dark urine, contact your vet right away. Most dogs will never have this reaction, but early recognition matters. It is also helpful to tell your vet about any previous immune-mediated disease, transfusions, toxin exposure, or recent travel.

For dogs recovering from IMHA, prevention focuses on relapse monitoring rather than complete prevention. Give medications exactly as prescribed, and do not stop steroids or other immunosuppressants abruptly unless your vet tells you to. Many dogs need a slow taper over months.

At home, watch gum color, energy level, breathing at rest, appetite, and urine color. If your dog becomes suddenly weak, breathes hard, or looks pale or yellow again, see your vet immediately. Follow-up bloodwork is one of the most important parts of care because relapse can show up on lab work before it is obvious at home.